Condition
Haplo-identical Donors
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Supertransplantation In 3 Severe Β Thalassemia Pediatric Patients
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Supertransplantation In 3 Severe Β Thalassemia Pediatric Patients1
Active Sponsors
- Guangzhou Women and Children's Medical Center1
Top Investigators
Guangzhou Medical University Affiliated Women's and Children's Medical Center
Related Conditions
- Thalassemia Majors Betathalassemia Major1